Clinical Trial: Use of TpCO2 (Transcutaneous CO2 Measurement) as PaCO2 Predictor During NIV in Case of Acute Hypercapnic Respiratory Failure

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Use of TpCO2 (Transcutaneous CO2 Measurement)as PaCO2 Predictor During Non Invasive Ventilation (NIV) in Case of Acute Hypercapnic Respiratory Failure

Brief Summary: In patients suffering from hypercapnic respiratory failure and treated by non invasive ventilation (NIV), the interest of using transcutaneous CO2 measurement to evaluate PaCO2 and PaCO2 variation over time is unknown and will be evaluated in this study. Measurements will be done during one-hour NIV treatments.

Detailed Summary:
Sponsor: University of Lausanne Hospitals

Current Primary Outcome: Comparison between TpCO2 (transcutaneous non invasive CO2 partial pressure measurement) and PaCO2 (obtained by blood gas analysis) values during NIV treatment. [ Time Frame: sixty minutes ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Lausanne Hospitals

Dates:
Date Received: May 15, 2013
Date Started: February 2013
Date Completion:
Last Updated: June 7, 2015
Last Verified: June 2015